References
- Fujiwara N, Kobayashi K. Macrophages in Inflammation. Curr Drug Targets Inflamm Allergy. 2005;4(3):281-6, https://doi.org/10.2174/1568010054022024
- Kimbrell DA, Beutler B. The evolution and Genetics of Innate Immunity. Nat Rev Genet. 2001;2(4):256-67. https://doi.org/10.1038/35066006
- Zhang H, Wu ZM, Yang YP, Shaukat A, Yang J, Guo YF, Zhang T, Zhu XY, Qiu JX, Deng GZ, Shi DM. Catalpol Ameliorates LPS-induced Endometritis by Inhibiting Inflammation and TLR4/NF-kappaB Signaling. J Zhejiang Univ Sci B. 2019;20(10):816-27. https://doi.org/10.1631/jzus.b1900071
- Israel A. The IKK Complex, a Central Regulator of NF-kappaB Activation. Cold Spring Harb Perspect Biol. 2010;2(3):a000158. https://doi.org/10.1101/cshperspect.a000158
- Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, Wu P, Wiesmann C, Baker R, Boone DL, Ma A, Koonin EV, Dixit VM. De-ubiquitination and Ubiquitin Ligase Domains of A20 Downregulate NF-kappaB Signalling. Nature. 2004;430(7000):694-9. https://doi.org/10.1038/nature02794
- Catrysse L, Vereecke L, Beyaert R, van Loo G. A20 in Inflammation and Autoimmunity. Trends Immunol. 2014;35(1):22-31. https://doi.org/10.1016/j.it.2013.10.005
- Lin SC, Chung JY, Lamothe B, Rajashankar K, Lu M, Lo YC, Lam AY, Darnay BG, Wu H. Molecular Basis for the Unique Deubiquitinating Activity of the NF-kappaB Inhibitor A20. J Mol Biol. 2008;376(2):526-40. https://doi.org/10.1016/j.jmb.2007.11.092
- Robledinos-Anton N, Fernandez-Gines R, Manda G, Cuadrado A. Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development. Oxid Med Cell Longev. 2019;2019:9372182.
- Yan C, Zhang X, Miao J, Yuan H, Liu E, Liang T, Li Q. Farrerol Directly Targets GSK-3beta to Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries. Oxid Med Cell Longev. 2020;2020:5967434.
- Hwang DY. Banyakhapeon. Seoul:Yonglim Books, 2010. p. 548-9.
- Ministry of Food and Drug Safety. The Korean Herbal Pharmacopoeia. Republic of Korea:Ministry of Food and Drug Safety; 2020.
- Al-Snafi AE. The Pharmacological Importance of Benincasa hispida. A review. International Journal of Pharma Sciences and Research (IJPSR). 2013;4(12):165-70.
- Lee KH, Choi HR, Kim CH. Anti-angiogenic Effect of the Seed Extract of Benincasa Hispida Cogniaux. J Ethnopharmacol. 2005;97(3):509-13. https://doi.org/10.1016/j.jep.2004.12.008
- Choi JY KS, Kwun MJ, Kim K.H., Joo M, Han C. Effects of Ethanol Extract of Benincasa Seeds on the Experimental Cellular Model of Nonalcholic Fatty Liver Disease. Korean J Orinet Int Med. 2012;33(4):438-47.
- An SM, Kim HG, Choi EJ, Hwang HH, Lee E, Baek JH, Boo YC, Koh JS. Screening for Anti-inflammatory Activities in Extracts from Korean Herb Medicines. J Soc Cosmet Scientists Korea. 2014;40(1);95-108. https://doi.org/10.15230/SCSK.2014.40.1.95
- Park Gi, Lee JA. Anti-oxidant, Anti-inflammatory and Whitening Effect of Benincasa hispida Seed Extract. Journal of Convergence for Information Technology. 2020;10(7):249-56. https://doi.org/10.22156/CS4SMB.2020.10.07.249
- Park SK, Kim JJ, Sung SMi, Lee MY. Suppressive Effects of Benincasae hispida on Allergic Inflammation. Molecular & Cellular Toxicology 2009;5(4):304-9.
- Kim KH, Kim DH, Jeong N, Kim KI, Kim YH, Lee M, Choi JY, Jung HJ, Jung SK, Joo M.: Therapeutic Effect of Chung-Pae, an Experimental Herbal Formula, on Acute Lung Inflammation Is Associated with Suppression of NF-κB and Activation of Nrf2, Evid Based Complement Alternat Med. 2013;2013:659459.
- Zhang Q, Lenardo MJ, Baltimore D.30 Years of NF-kappaB: A Blossoming of Relevance to Human Pathobiology. Cell. 2017;168(1):37-57. https://doi.org/10.1016/j.cell.2016.12.012
- Sinnongbonchogyeong. Seoul: Euisungdang; 2012.
- Kumazawa Y, Nakatsuru Y, Yamada A, Yadomae T, Nishimura C, Otsuka Y, Nomoto K. Immunopotentiator Separated from Hot Water Extract of the Seed of Benincasa cerifera Savi (Tohgashi). Cancer Immunol Immunother. 1985;19(2):79-84. https://doi.org/10.1007/BF00199713
- Broad A, Jones DE, Kirby JA. Toll-like Receptor (TLR) Response Tolerance: a Key Physiological "Damage Limitation" Effect and an Important Potential Opportunity for Therapy. Curr Med Chem. 2006;13(21):2487-502. https://doi.org/10.2174/092986706778201675
- Miller SI, Ernst RK, Bader MW. LPS, TLR4 and Infectious Disease Diversity. Nat Rev Microbiol. 2005;3(1):36-46. https://doi.org/10.1038/nrmicro1068
- M Bhatia, S Moochhala. Role of Inflammatory Mediators in the Pathophysiology of Acute Respiratory Distress Syndrome. J Pathol. 2004;202:145-56. https://doi.org/10.1002/path.1491